Fabtech

What Fabtech does

Fabtech Technologies Ltd. is a Mumbai-headquartered public Indian engineering firm (BSE: 544558) that delivers turnkey pharmaceutical and biotechnology manufacturing facilities globally, with operations spanning 53 countries and a reference base of 700+ completed projects. The company's offering covers the full facility lifecycle — design, engineering, supply, installation, validation and commissioning — and is organized into four solution areas: Start-to-Finish turnkey projects; Solutions for Air (modular cleanroom panels, HVAC, HEPA-filtered laminar airflow systems, air showers, VHP pass-through chambers, sterility testing and potent API isolators); Solutions for Water (purification and high-purity distribution); and Solutions for Process (granulation, tablet compression, auto-coating, encapsulation, containment systems, inhaler/nebuliser lines, liquid filling, sterilising tunnels, and the FilPac prefilled syringe system). Proprietary technology includes the FabAssure real-time web-based project management system for global project tracking.

The business operates on three revenue streams: turnkey project contracts (professional services, recognized at milestones), equipment supply (hardware sales, standalone or bundled), and validation/qualification services (URS, DQ, FAT, SAT, IQ, OQ, PQ testing). Go-to-market is exclusively direct enterprise field sales — no resellers, distributors, or self-service channels — targeting pharmaceutical companies, biotech firms, government health facilities, and research institutions. Pricing is project-specific and non-public given customization per scope, complexity, and geography.

The company's competitive positioning rests on execution capability in challenging geographies where European competitors decline to operate (notably across Africa, LATAM, and South Asia), proprietary modular cleanroom technology certified to BS 476 part b with 2-hour fire rating from Dubai Civil Defence, and a track record of rescuing stalled projects. Customer references include Fidson Healthcare (Nigeria, largest pharma plant in West Africa), Mechnikov (Nicaragua vaccine facility, 30 million doses/year), Sudair Pharma (Saudi Arabia, Novartis-partnered oncology facility), Umicore (Argentina containment), and Government of Uttar Pradesh (BSL-3 labs). Two wholly-owned subsidiaries — FABL International Technologies LLP and Mark Maker Engineering Pvt Ltd — support engineering operations. The company filed IPO documents in 2025 and lists on BSE under ticker BOM:544558.

Name

Fabtech

Legal name

Fabtech Technologies Ltd.

Website

https://fabtechnologies.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Fabtech Technologies Ltd. is a Mumbai-based public Indian engineering firm delivering turnkey pharmaceutical and biotech manufacturing facilities across 53 countries, offering end-to-end cleanroom, HVAC, water, and process equipment solutions with 700+ completed projects.

Ownership category

akta.pro rank

Product category

Pharmaceutical Turnkey Engineering Solutions

NAICS

Scientific Research and Development Services (5417), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Laboratory Apparatus & Furniture (3821)

akta.pro primary industry

Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)

akta.pro secondary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

• Pharmaceutical engineering solutions
• Turnkey pharma projects
• Cleanroom systems manufacturing
• Pharmaceutical process equipment
• HVAC pharma systems

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Turnkey Project Contracts: Full-service project contracts encompassing design, engineering, supply, installation, validation and commissioning of pharmaceutical manufacturing facilities. Revenue recognized upon project completion with milestones throughout execution.
2. Equipment Supply: Supply of pharmaceutical equipment including cleanroom systems, HVAC, water treatment, process equipment, containment solutions and modular panels. Can be standalone or bundled with turnkey projects.
3. Validation and Qualification Services: Equipment qualification services following pharmaceutical industry standards including URS, DQ, FAT, SAT, IQ, OQ, PQ testing and documentation support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Fabtech delivers end-to-end turnkey engineering and fabrication solutions for pharmaceutical, biotechnology, and healthcare manufacturers. The offering spans the full project lifecycle — design, engineering, supply, installation, validation, and commissioning — covering cleanroom and HVAC systems, high-purity water treatment, process equipment (granulation, tablet compression, encapsulation, liquid filling, prefilled syringes), containment isolators, and BSL-3 laboratory facilities. The company also performs GMP-aligned equipment qualification and validation services for clients globally.

Product overview

Fabtech is a leading pharmaceutical turnkey solution provider offering start-to-finish engineering solutions for pharmaceutical, biotech and healthcare companies globally. The product portfolio is organized into four main solution areas: Start-to-Finish (Turnkey) Solutions covering the complete project lifecycle; Solutions for Air including cleanroom systems, HVAC, modular panels, air showers, pass-through chambers, and isolators (Sterility Testing, PAPI); Solutions for Water covering water purification and high-purity water systems; and Solutions for Process including granulation lines, tablet compression, auto coaters, encapsulation, containment systems, inhaler/nebuliser manufacturing, liquid filling, sterilising tunnels, and the FilPac prefilled syringe system. The company also provides proprietary project management software (FabAssure) and equipment qualification/validation services following URS, DQ, FAT, SAT, IQ, OQ, and PQ protocols. Fabtech has delivered over 700 projects in 53 countries serving pharmaceutical, biotech, healthcare, food & beverages, IT, and defence sectors.

Differentiator

Problem solved

Functional benefit

Brands

• FabAssure: Proprietary real-time web-based Project Management System used for tracking project activities from day one and providing real-time project status updates.

Products and services

• Start-to-Finish (Turnkey) Solutions Comprehensive end-to-end engineering solutions for pharmaceutical, biotech and healthcare companies, covering the entire project lifecycle from design through installation, validation and commissioning.
• Solutions for Air (Cleanroom & HVAC) Environmental control solutions including cleanroom systems, HVAC systems, air filtration, and temperature/humidity management for pharmaceutical manufacturing facilities.
• Solutions for Water Equipment and systems for water purification and high-purity water generation and distribution for pharmaceutical manufacturing.
• Solutions for Process Process equipment including granulation lines, tablet compression, auto coaters, encapsulation lines, containment systems, and liquid filling equipment for pharmaceutical manufacturing.
• Modular Cleanroom Panel Systems

Quantifiable outcome

• Largest pharma facility in Nigeria and West Africa - operational for 19+ months without malfunctions
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• NovartissignificantStrategic or Co-development Partner · 1 April 2019Novartis signed a memorandum of understanding with Sudair Pharma in April 2019 to collaborate on local manufacturing of cancer drugs in the Kingdom of Saudi Arabia. Fabtech completed the Sudair facility which specializes in oncology OSDs and Injectables.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CRB Group: US-based engineering, architecture and construction firm focused exclusively on life sciences facilities. Closest like-for-like competitor to Fabtech's turnkey pharmaceutical/biotech facility design and construction business, serving the same global customer base of pharma and biotech manufacturers.
• NNE (Novo Nordisk Engineering): Denmark-headquartered engineering firm providing pharma facility design, process engineering and validation services globally. Direct peer in pharma EPC and qualification services, with overlapping customer segments and similar turnkey project model.
• IPS (Integrated Project Services): US-based engineering firm specializing in pharmaceutical and biotechnology facility design, construction management and validation. Directly comparable to Fabtech in delivering GMP-compliant turnkey projects for drug manufacturers.
• DPS Group: Ireland-headquartered global engineering and construction management firm serving the pharma, biotech and medtech sectors. Competes head-to-head with Fabtech on turnkey facility projects, cleanroom design and process engineering services.
• Commissioning Agents Inc (CAI): US-based engineering services firm focused on commissioning, qualification and validation services for pharma and biotech facilities. Comparable to Fabtech's qualification/validation (URS through PQ) service line and shared pharma customer base.

Broad incumbents

• GEA Group: German global technology company with a large pharma and food process equipment and engineering division. Overlaps with Fabtech in pharmaceutical process equipment, separation and liquid processing, though as a much larger incumbent serving broader industries.
• IMA Group: Italian global leader in automatic machinery for pharmaceutical packaging and processing. Competes with Fabtech's process equipment line (granulation, tablet compression, encapsulation, liquid filling) but at significantly larger scale and broader portfolio.
• Syntegon Technology: German global process and packaging technology company (formerly Bosch Packaging Technology) serving the pharma and food industries. Overlaps with Fabtech in pharma processing and packaging equipment as a much larger incumbent.
• Jacobs Solutions: Global engineering, professional services and EPC firm with a meaningful life sciences practice. Competes with Fabtech on large pharma facility EPC projects but as a much larger, diversified infrastructure and consulting giant.

Regional players

• GMM Pfaudler: Indian-listed global manufacturer of process equipment (glass-lined reactors, agitators, filtration) serving pharmaceutical and chemical manufacturers. Indian peer to Fabtech's process equipment business with overlapping pharmaceutical customers but primarily a product manufacturer rather than EPC firm.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fabtechnologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fabtech